Mock Hettiaratchi Lab News

Department of Bioengineering

The Hettiaratchi Lab

Biomaterials for protein delivery and tissue engineering

Hettiaratchi Lab News

 

Knight Campus News featured Justin and Chandler's work published in Biomacromolecules and the Journal of Controlled Release.

The Knight Campus had strong representation at both the Society for Biomaterials (SFB) conference and the Orthopaedic Research Society (ORS) annual meeting last week.

Bioengineer Marian Hettiaratchi is the inaugural recipient of the Lary Simpson Professorship.

We're proud to have a strong presence at the Society For Biomaterials 2026 meeting in Atlanta, Georgia. Our students, postdocs, and faculty from labs throughout the Knight Campus Bioengineering department are presenting research across drug delivery, tissue engineering, and regenerative medicine.

Two bioengineers from the Phil and Penny Knight Campus for Accelerating Scientific Impact have been elected to leadership positions in the Tissue Engineering and Regenerative Medicine International Society (TERMIS), a group dedicated to advancing tissue engineering and regenerative medicine worldwide to improve patient outcomes globally.

Knight Campus graduate students Anissa Benabbas (Plesa Lab) and Malvika Singhal (Hettiaratchi Lab) took first place in the Science Coalition Student Video Challenge.

Researchers from the Hettiaratchi lab at Phil and Penny Knight Campus for Accelerating Scientific Impact combine 3D printing with molecular cues to guide muscle regeneration.

We're at BMES 2025! Visit us at booth #217 to learn more about our programs. 

Marian Hettiaratchi, Ph.D., was recently promoted to Associate Professor with indefinite tenure in the Department of Bioengineering.

The Hettiaratchi Lab 

Founded in 2020, the Hettiaratchi Lab is a biomaterial and protein engineering research group within the University of Oregon's Phil and Penny Knight Campus for Accelerating Scientific Impact. Based in the Department of Bioengineering in Eugene, Oregon, the Hettiaratchi Lab design biomaterials to control protein delivery to injured tissues.